Literature DB >> 22364715

Stakeholders involvement by HTA Organisations: why is so different?

Marianna Cavazza1, Claudio Jommi.   

Abstract

OBJECTIVE: To investigate stakeholder involvement by Health Technology Assessment Organisations (HTAOs) in France, Spain, England and Wales, Germany, Sweden, and The Netherlands and to examine whether this involvement depends on (i) the administrative tradition and the relevant conception of the relationship between state and society (contractarian and corporative vs. organic), (ii) the general structure of the healthcare system (HCS) (Bismarckian vs. Beveridgian system), and (iii) the role of Health Technology Assessment (HTA) and HTAOs in the HCS.
METHODS: Given the exploratory nature of the study, we considered interviews based on semi-structured questionnaires the most appropriate data-gathering technique. The interviews were administered to 16 key personnel in the HTAOs concerned. We have also carried out a literature review on HTAOs and stakeholders (1999-2011) using PubMed, Ebsco, JSTOR and Wiley Science.
RESULTS: In contractarian and (to a lesser extent) Bismarckian models, stakeholders are more involved. The administrative tradition and the HCS appear less important when the HTA is binding and used for regulatory purposes. In such situations, stakeholders are more intensively involved because their participation provides an opportunity for HTAOs to achieve consensus and legitimacy in advance.
CONCLUSIONS: Despite the limitations of the research (we did not conduct multiple interviews for each HTAO, and key informants were not always available) and its exploratory nature, we can conclude that models of stakeholders involvement cannot easily be transferred from one country to another due to the importance of national administrative traditions and the characteristics of HCSs.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2012        PMID: 22364715     DOI: 10.1016/j.healthpol.2012.01.012

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  5 in total

1.  Does the approach to economic evaluation in health care depend on culture, values, and institutional context?

Authors:  Aleksandra Torbica; Rosanna Tarricone; Michael Drummond
Journal:  Eur J Health Econ       Date:  2018-07

Review 2.  Patient and Public Involvement in the Development of Healthcare Guidance: An Overview of Current Methods and Future Challenges.

Authors:  Ahmed Rashid; Victoria Thomas; Toni Shaw; Gillian Leng
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

3.  Sharing Frailty-related information in perioperative care: an analysis from a temporal perspective.

Authors:  Daniel Fürstenau; Claudia Spies; Martin Gersch; Amyn Vogel; Rudolf Mörgeli; Akira-Sebastian Poncette; Ursula Müller-Werdan; Felix Balzer
Journal:  BMC Health Serv Res       Date:  2019-02-07       Impact factor: 2.655

4.  Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries.

Authors:  Maria Dimitrova; Ivett Jakab; Zornitsa Mitkova; Maria Kamusheva; Konstantin Tachkov; Bertalan Nemeth; Antal Zemplenyi; Dalia Dawoud; Diana M J Delnoij; François Houýez; Zoltan Kalo
Journal:  Front Public Health       Date:  2022-07-28

5.  Envisioning and shaping translation of knowledge into action: A comparative case-study of stakeholder engagement in the development of a European tobacco control tool.

Authors:  Robert A J Borst; Maarten Olivier Kok; Alison J O'Shea; Subhash Pokhrel; Teresa H Jones; Annette Boaz
Journal:  Health Policy       Date:  2019-07-20       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.